MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development Home > Business > Article
3 years ago By Bryan — NEW YORK, May 13, 2021 /CNW/ -- MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic-inspired medicine company has appointed Peter Mack PhD
#mindmedbolstersmanagementteam #appointspetermackphd #pharmaceutical